---
title: "Nano Dimension outlines proposed Infinite Epigenetics merger, 20% premium to cash value"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290100611.md"
description: "Nano Dimension announced a proposed business combination with Infinite Epigenetics, offering shareholders a 20% premium to its cash value through ownership in the combined entity. The deal aims to deploy Nano's cash to accelerate Infinite’s commercialization and build a proprietary biological AI platform. Nano selected Infinite after a months-long review, citing its CLIA lab and existing revenue. The company plans to file proxy materials and hold an extraordinary general meeting for shareholder approval."
datetime: "2026-06-17T20:13:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290100611.md)
  - [en](https://longbridge.com/en/news/290100611.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290100611.md)
generator: "portal-rs"
---

# Nano Dimension outlines proposed Infinite Epigenetics merger, 20% premium to cash value

**Nano Dimension announced additional details on a proposed business combination with Infinite Epigenetics and said the deal would offer shareholders a 20% premium to the company’s cash value through ownership in the combined entity.**

**Key Highlights:**

-   Filed Form 8-K disclosing a press release and furnished Exhibit 99.1 with details on the proposed transaction.
-   Board selected Infinite after a months-long review, citing its CLIA lab, >120,000 methylation samples and existing commercial revenue.
-   Transaction aims to deploy Nano’s cash to accelerate Infinite’s commercialization and build a proprietary biological AI platform.
-   Term sheet contemplates shareholders receiving a 20% premium to Nano’s cash value via ownership in the combined company.
-   Company plans proxy filings (preliminary proxy, Form S-4/Proxy Statement/Prospectus) and an extraordinary general meeting for shareholder vote.

Original SEC Filing: Nano Dimension Ltd. \[ NNDM \] - 8-K - Jun. 17, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [NNDM.US](https://longbridge.com/en/quote/NNDM.US.md)

## Related News & Research

- [Nano Dimension director Pinchos Fruchthandler files initial beneficial ownership statement](https://longbridge.com/en/news/296826283.md)
- [NNDM: Nano and Infinite propose a merger to form an AI-driven preventive health diagnostics leader](https://longbridge.com/en/news/289796212.md)
- [The Biggest Players in a $500 Billion Market Are Exiting. Here’s Why Costco Just Entered.](https://longbridge.com/en/news/296526358.md)
- [Roche unit Flatiron expands NSCLC Panoramic dataset with specimen-level biomarker model across 345,000+ patients](https://longbridge.com/en/news/296919271.md)
- [EH: Revenues soared 203.5% QoQ, but regulatory caution in China clouds near-term outlook](https://longbridge.com/en/news/296894241.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**